Prakt. lékáren. 2020; 16(3): 159-164

Biofilm and phytopharmaceuticals

Vilma Vranová
Farmaceutická fakulta, Veterinární a farmaceutická univerzita, Brno

Acute urinary tract infection is a very common disease in the adult population. It holds true that much more significant treatment difficulties are encountered in the case of chronic and recurrent bacterial infections than in acute ones. Biofilm formation is another important factor, allowing prolonged survival of bacteria and, thus, making treatment of bacterial infections more difficult. Given the limited options of antibacterial therapy, other possibilities of helping patients in an effective way are, of course, being sought. These traditionally include the use of phytopharmaceuticals, i.e. herbal medicinal products. The paper deals with the possible use of registered pharmaceutical products of plant origin in treating acute urinary tract infections.

Keywords: E. coli, urinary tract infection, biofilm, phytopharmaceuticals.

Published: October 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vranová V. Biofilm and phytopharmaceuticals. Praktické lékárenství. 2020;16(3):159-164.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Terlizzi ME, Gribaudo G, et al. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front. Microbiol. 2017; 8: 1566. Go to original source... Go to PubMed...
    2. Werneburg GT, Henderson NS, et al. The pilus usher controls protein interactions via domain masking and is functional as an oligomer. Nat. Struct. Mol. Biol. 2015; 22: 540-546. Go to original source... Go to PubMed...
    3. Bien J, Sokolova O, et al. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol. 2012: 2012: 681473. doi: 10.1155/2012/681473. Go to original source... Go to PubMed...
    4. Surgers L, Boyd A, et al. Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella Pneumoniae. International Journal of Medical Microbiology 2019; 309: 13-18. Go to original source... Go to PubMed...
    5. Lhotský J. Úvod do studia symbiotických interakcí mikroorganismů: nový pohled na viry a bakterie. Praha: Academia, 2015.
    6. EAU [online]. EAU Guidelines Urological infection. Uncomplicated cystitis [Cit. 1. 11. 2019]. Dostupné na: https://uroweb.org/guideline/urological-infections/#3_4.
    7. Basu S, Mukherjee M. Incidence and risk of co-transmission of plasmid-mediated quinolone resistance and extended-spectrum β-lactamase genes in fluoroquinolone-resistant uropathogenic Escherichia coli: a first study from Kolkata, India, Journal of Global Antimicrobial Resistance 2018; 14: 217-223. Go to original source... Go to PubMed...
    8. SUKL [online]. Furolin - SPC. Databáze léků. [Cit. 1. 11. 2019]. Dostupné na: http://www.sukl.cz/modules/medication/detail.php?code=0213944&tab=prices.
    9. Česká urologická společnost [online]. Informace SÚKL. Furolin. [Cit. 1. 11. 2019]. Dostupné na: http://www.cus.cz/?s=furolin.
    10. EAU [online]. EAU Guidelines Urological infection. Disease management [Cit. 1. 11. 2019]. Dostupné na: https://uroweb.org/guideline/urological-infections/#3.
    11. Yap PS, Yiap BC, et al. Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance. The Open Microbiology Journal 2014; 8: 6-14. Go to original source... Go to PubMed...
    12. Shimizu M, Shiota S, et al. Marked potentiation of activity of β-lactams against methicillin-resistant Staphylococcus aureus by corilagin, Antimicrob. Agents Chemother. 2001; 45: 3198-3201. Go to original source... Go to PubMed...
    13. Afshar K, Fleischmann N, et al. Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) - a double-blind, randomized, controlled comparative effectiveness trial BMC Complementary and Alternative Medicine 2018; 18: 203. Go to original source... Go to PubMed...
    14. Chrubasik JE, Roufogalis BD, et al. A comprehensive review on the stinging nettle effect and efficacy profiles. Phytomedicine 2007; 14: 568-579. Go to original source... Go to PubMed...
    15. Rafsanjany N, Lechtenberg M, et al. Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: In vitro studies with traditionally used plants with antiadhesive activity against uropathognic Escherichia coli. Journal of Ethnopharmacology 2013; 145: 591-597. Go to original source... Go to PubMed...
    16. Ghusoon A. Synergism effect of rosemary essential oil and some antibiotic against Escherichia coli isolated from clinical samples. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) 12, 2 Ver. III: 39-42.
    17. Tawab AA, El-Hofy FI, et al. Synergistic effect between some antimicrobial agents and rosemary (Rosmarinus officinalis) toward Staphylococcus aureus in-vitro. Benha Vet Med J 2015; 28: 195-201. Go to original source...
    18. Sienkiewicz M, Łysakowska M, et al. The Potential of Use Basil and Rosemary Essential Oils as Effective Antibacterial Agents. Molecules 2013; 18: 9334-9351. doi: 10.3390/molecules18089334. Go to original source... Go to PubMed...
    19. Shaaban HA, Ahmed MBM, et al. Study on the antimicrobial activity and synergistic/antagonistic effect of interactions between antibiotics and some spice essential oils against pathogenic and food-spoiler microorganisms. J Appl Sci Res 2013; 9: 5076-5085.
    20. Hassani FV, Shirani K, et al. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review Arch Pharmacol 2016; 389: 931. https://doi.org/10.1007/s00210-016-1256-0. Go to original source... Go to PubMed...
    21. Moore J, Yousef M, et al. Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients. 2016; 8(11): 17. Go to original source... Go to PubMed...
    22. Ebrahimi A, Eshraghi A, et al. Antibacterial and Antibiotic-Potentiation Activities of Levisticum officinale L. Extracts on Pathogenic Bacteria, Int J Infect. 2017; 4(2): e38768. doi: 10.5812/iji.38768. Go to original source...
    23. Garvey MI, Rahman M, et al. Medicinal plant extractswith efflux inhibitory activity against Gram-negative bacteria. International Journal of Antimicrobial Agents, Elsevier, 2011; 37(2): 145. doi: 10.1016/j.ijantimicag.2010.10.027. Go to original source... Go to PubMed...
    24. Seukep AJ, Kuete V, et al. Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification, Journal of Pharmaceutical Analysis 2019. doi: https://doi.org/10.1016/j.jpha.2019.11.002 Go to original source... Go to PubMed...
    25. Grube K, Spiegler V, et al. Antiadhesive phthalides from Apium graveolens fruits against uropathogenic E. coli, Journal of Ethnopharmacology 2019; 237: 300-306. https://doi.org/10.1016/j.jep.2019.03.024. Go to original source... Go to PubMed...
    26. Kumarasamy Y, Nahar L, et al. Bioactivity of secoiridoid glycosides from Centaurium erythraea. Phytomedicine 2003; 10: 344-347. Go to original source... Go to PubMed...
    27. Siler B, Zivković S, et al. Centauries as underestimated food additives: Antioxidant and antimicrobial potential. Food Chemistry 2014; 147: 367-376. Go to original source... Go to PubMed...
    28. SUKL [online]. Canephron SPC. Databáze léků. [Cit. 1. 11. 2019]. Dostupné na: https://www.sukl.sk/hlavna-stranka/slovenska-verzia/pomocne-stranky/detail-lieku?page_id=386&lie_id=86821.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.